Ikuta Y - Search Results

1

Plasma matrix metalloproteinase-9 (gelatinase B) in patients with hepatocellular carcinoma.

Murawaki Y, Ikuta Y, Okamoto K, Mimura K, Koda M, Kawasaki H. Murawaki Y, et al. Among authors: ikuta y. Res Commun Mol Pathol Pharmacol. 2000 Nov-Dec;108(5-6):351-7. Res Commun Mol Pathol Pharmacol. 2000. PMID: 11958288 Clinical Trial.

2

The proMMP-2 activation rate in patients with chronic viral liver disease.

Murawaki Y, Ikuta Y, Koda M, Okamoto K, Mimura K. Murawaki Y, et al. Among authors: ikuta y. Clin Chim Acta. 2002 Oct;324(1-2):99-103. doi: 10.1016/s0009-8981(02)00239-5. Clin Chim Acta. 2002. PMID: 12204430

3

Serum amino acid levels and hepatic protein synthesis during liver regeneration after partial hepatectomy in rats.

Murawaki Y, Ikuta Y, Yamamoto H, Kawasaki H. Murawaki Y, et al. Among authors: ikuta y. Res Commun Chem Pathol Pharmacol. 1992 Jul;77(1):43-54. Res Commun Chem Pathol Pharmacol. 1992. PMID: 1439180

4

Clinical evaluation of a monoclonal antibody to serum KM01 for the diagnosis of hepatocellular carcinoma.

Fujii T, Horie Y, Ikuta Y, Nishimuki E, Murawaki Y, Suou T, Kawasaki H. Fujii T, et al. Among authors: ikuta y. Clin Chim Acta. 1995 Apr 30;236(1):71-9. doi: 10.1016/0009-8981(95)06042-6. Clin Chim Acta. 1995. PMID: 7545092

5

Serum markers for fibrosis and plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma in comparison with patients with liver cirrhosis.

Murawaki Y, Ikuta Y, Nishimura Y, Koda M, Kawasaki H. Murawaki Y, et al. Among authors: ikuta y. J Gastroenterol Hepatol. 1996 May;11(5):443-50. doi: 10.1111/j.1440-1746.1996.tb00289.x. J Gastroenterol Hepatol. 1996. PMID: 8743916

6

Tissue inhibitor of metalloproteinase-1 in the liver of patients with chronic liver disease.

Murawaki Y, Ikuta Y, Idobe Y, Kitamura Y, Kawasaki H. Murawaki Y, et al. Among authors: ikuta y. J Hepatol. 1997 Jun;26(6):1213-9. doi: 10.1016/s0168-8278(97)80454-0. J Hepatol. 1997. PMID: 9210606

7

Molecular weight of hyaluronate in the serum of patients with chronic liver disease.

Murawaki Y, Ikuta Y, Idobe Y, Koda M, Kawasaki H. Murawaki Y, et al. Among authors: ikuta y. Res Commun Mol Pathol Pharmacol. 1998 Feb;99(2):207-16. Res Commun Mol Pathol Pharmacol. 1998. PMID: 9583094

8

Serum matrix metalloproteinase-1 in patients with chronic viral hepatitis.

Murawaki Y, Ikuta Y, Idobe Y, Kawasaki H. Murawaki Y, et al. Among authors: ikuta y. J Gastroenterol Hepatol. 1999 Feb;14(2):138-45. doi: 10.1046/j.1440-1746.1999.01821.x. J Gastroenterol Hepatol. 1999. PMID: 10029294

9

Clinical usefulness of serum tissue inhibitor of metalloproteinases (TIMP)-2 assay in patients with chronic liver disease in comparison with serum TIMP-1.

Murawaki Y, Ikuta Y, Kawasaki H. Murawaki Y, et al. Among authors: ikuta y. Clin Chim Acta. 1999 Mar;281(1-2):109-20. doi: 10.1016/s0009-8981(98)00215-0. Clin Chim Acta. 1999. PMID: 10217632

10

Clinical usefulness of serum matrix metalloproteinase-2 concentration in patients with chronic viral liver disease.

Murawaki Y, Yamada S, Ikuta Y, Kawasaki H. Murawaki Y, et al. Among authors: ikuta y. J Hepatol. 1999 Jun;30(6):1090-8. doi: 10.1016/s0168-8278(99)80264-5. J Hepatol. 1999. PMID: 10406188

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

460 results

Search Page

Filters